Valuation: Thermo Fisher Scientific Inc.

Capitalization 214B 206B 194B 174B 307B 18,455B 342B 2,361B 875B 7,614B 803B 786B 33,324B P/E ratio 2024 *
34.4x
P/E ratio 2025 * 30.7x
Enterprise value 240B 231B 218B 195B 344B 20,694B 383B 2,648B 981B 8,537B 900B 882B 37,367B EV / Sales 2024 *
5.61x
EV / Sales 2025 * 5.23x
Free-Float
86.06%
Yield 2024 *
0.27%
Yield 2025 * 0.29%
More valuation ratios * Estimated data
Dynamic Chart
1 day-0.37%
1 week+0.74%
Current month+7.58%
1 month+6.79%
3 months-6.99%
6 months+4.73%
Current year+7.58%
More quotes
1 week
544.06
Extreme 544.06
565.00
1 month
515.77
Extreme 515.77
565.00
Current year
518.09
Extreme 518.09
565.00
1 year
493.30
Extreme 493.3
627.88
3 years
415.60
Extreme 415.6
627.88
5 years
250.21
Extreme 250.21
672.34
10 years
117.10
Extreme 117.1
672.34
More quotes
Director TitleAgeSince
Chief Executive Officer 57 2009-10-14
Director of Finance/CFO 58 2015-07-31
Chief Tech/Sci/R&D Officer - 2023-09-30
Manager TitleAgeSince
Director/Board Member 67 2006-11-08
Chairman 57 2020-02-25
Director/Board Member 64 2009-05-25
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
-0.37%+0.74%+1.43%-4.85%214B
+1.47%+9.80%+58.11%+102.45%211B
-1.46%-0.63%+3.16%-15.76%172B
+0.50%+4.28%+61.90%+127.07%145B
-0.08%+2.68%+0.23%-15.75%60.64B
+1.82%+3.81%+12.30%+5.65%42.09B
-0.11%-1.84%-6.10%-39.62%41.16B
-0.31%-0.73%+14.34% - 38.72B
+1.09%+2.14%-14.54%-33.40%39.16B
+1.12%+4.13%+38.97%+0.76%35.21B
Average +0.36%+2.44%+16.98%+14.06% 99.97B
Weighted average by Cap. +0.19%+3.60%+23.76%+34.05%
See all sector performances

Financials

2024 *2025 *
Net sales 42.81B 41.16B 38.86B 34.8B 61.3B 3,691B 68.36B 472B 175B 1,523B 161B 157B 6,664B 44.83B 43.11B 40.7B 36.45B 64.19B 3,865B 71.59B 494B 183B 1,595B 168B 165B 6,979B
Net income 6.14B 5.91B 5.58B 4.99B 8.8B 530B 9.81B 67.75B 25.11B 218B 23.04B 22.56B 956B 6.77B 6.51B 6.14B 5.5B 9.69B 583B 10.8B 74.62B 27.65B 241B 25.37B 24.85B 1,053B
Net Debt 25.97B 24.98B 23.58B 21.12B 37.19B 2,239B 41.48B 286B 106B 924B 97.42B 95.41B 4,043B 20.46B 19.67B 18.57B 16.63B 29.29B 1,763B 32.67B 226B 83.61B 728B 76.72B 75.14B 3,184B
More financial data * Estimated data
Logo Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. specializes in the design, manufacturing and marketing of laboratory and scientific equipments. Net sales (including intragroup) break down by family of products as follows: - laboratory equipments (70%). Moreover, the group proposes chemical products (reagents, solvent, salts, etc.), consumable products (tubes, funnels, vials, etc.), as well as conditioning, warehousing, storage, etc.; - diagnostics equipment and products (15.3%); - scientific analysis equipments (14.7%): analyzer (of water, gas, grounds, etc.), mass spectrometers, molecular spectroscopes, microscopes, manometers, samplers, microbiology equipments, reactive agents, etc. Net sales break down by source of income into products sales (78.5%) and services (21.5%). Net sales break down geographically as follows: North America (53%), Europe (25.7%), Asia-Pacific (18.1%) and others (3.2%).
Employees
122,000
Calendar
More about the company
Date Price Change Volume
25-01-17 559.65 $ -0.37% 2,140,069
25-01-16 561.71 $ +1.86% 1,835,537
25-01-15 551.47 $ -0.99% 3,251,325
25-01-14 556.99 $ +0.26% 2,207,392

Delayed Quote Nyse, January 17, 2025 at 04:00 pm EST

More quotes
Trading Rating
Investor Rating
ESG MSCI
BB
surperformance-ratings-light-chart THERMO-FISHER-SCIENTIFIC-More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
32
Last Close Price
559.65USD
Average target price
645.22USD
Spread / Average Target
+15.29%
Consensus

Quarterly revenue - Rate of surprise